• Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials

Martin H. Steinberg, MD

Professor of Medicine
Boston University School of Medicine
72 East Concord Street
Boston, Massachusetts, United States

Dr. Steinberg is currently working as professor of medicine at Boston University School of Medicine. He is also associated with Center of Excellence in Sickle Cell Disease at Boston Medical Center. He holds board certifications both in internal medicine and hematology. His expertise includes clinical aspects of hemoglobinopathies and genetics of hemoglobin disorders. Dr. Steinberg’s clinical and research interests include sickle cell disease, inherited disorders of erythrocytes, fetal hemoglobin regulation and genotype-phenotype associations.


Representative Publications:

A Mild Phenotype of Severe ß+ Thalassemia in a 16-Month-Old Boy

Fetal hemoglobin in sickle cell anemia: The Arab-Indian haplotype and new therapeutic agents

A phased SNP-based classification of sickle cell anemia HBB haplotypes

Genetic determinants of HbF in Saudi Arabian and African Benin haplotype sickle cell anemia

Genome-wide association study to identify variants associated with acute severe vaso-occlusive pain in sickle cell anemia

Genetic modulation of fetal hemoglobin in hydroxyurea-treated sickle cell anemia

expertly curated content related to this topic

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.